NCT03363191 The Efficacy of Fluticasone Furoate/Vilanterol Versus (vs) Fluticasone Furoate on Asthma Status WITHDRAWN Phase PHASE4
NCT03361774 A Clinical Method Development Study to Characterise The Efficacy of a Dentifrice For The Relief Of Dentin Hypersensitivity Status WITHDRAWN Phase PHASE2
NCT03359473 Study to Evaluate the Safety and Efficacy of 13 Weeks of the Selective Androgen Receptor Modulator (SARM) GSK2881078 in Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE2
NCT03357341 Sensor and Electronic Health Records (EHR) Integration Pilot Study Status COMPLETED Phase N/A
NCT03355820 A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study Status COMPLETED Phase PHASE3
NCT03351140 Patient-Reported Outcome Measurement Information System (PROMIS) Physical Function Status COMPLETED Phase N/A
NCT03345407 Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) Status TERMINATED Phase PHASE2
NCT03345108 A Study to Investigate a Method to Measure Food Occlusion by Denture Adhesives in Denture Wearers Status COMPLETED Phase NA
NCT03344406 A Study to Evaluate Conceptual Saturation of Evaluating Respiratory Symptoms (E-RS) in Subjects With Asthma Status COMPLETED Phase N/A
NCT03336567 Perceptions of Cell and Gene Therapies (CGT) for the Treatment of Cancer Status COMPLETED Phase N/A
NCT03329573 Bioequivalence Study of Paroxetine Immediate Release (IR) Tablets Manufactured in GlaxoSmithKline Tianjin (GSKT) and Mississauga Sites in Healthy Chinese Subjects Status COMPLETED Phase PHASE1
NCT03329547 A Bioequivalence Study of SKF101804 Cefixime Versus Cefixime Reference Formulation in Healthy Adults Under Fasting Conditions Status WITHDRAWN Phase PHASE1
NCT03324633 Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV Status COMPLETED Phase N/A
NCT03318783 Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial Status COMPLETED Phase PHASE1/PHASE2